Natural products as potent inhibitors of hypoxia-inducible factor-1α in cancer therapy

Chin J Nat Med. 2020 Sep;18(9):696-703. doi: 10.1016/S1875-5364(20)60008-5.

Abstract

Hypoxia is a prominent feature of tumors. Hypoxia-inducible factor-1α (HIF-1α), a major subunit of HIF-1, is overexpressed in hypoxic tumor tissues and activates the transcription of many oncogenes. Accumulating evidence has demonstrated that HIF-1α promotes tumor angiogenesis, metastasis, metabolism, and immune evasion. Natural products are an important source of antitumor drugs and numerous studies have highlighted the crucial role of these agents in modulating HIF-1α. The present review describes the role of HIF-1α in tumor progression, summarizes natural products used as HIF-1α inhibitors, and discusses the potential of developing natural products as HIF-1α inhibitors for the treatment of cancer.

Keywords: Anticancer treatment; Cancer; Hypoxia; Hypoxia-inducible factor-1α; Natural products.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Biological Products / pharmacology*
  • Cell Line, Tumor
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / antagonists & inhibitors*
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Neoplasms / physiopathology*
  • Neovascularization, Pathologic / physiopathology

Substances

  • Antineoplastic Agents
  • Biological Products
  • Hypoxia-Inducible Factor 1, alpha Subunit